IP Library Assignment 048847/0256
Patent Assignment
Reel/Frame 048847/0256

Assignment of Assignor's Interest

Recorded: 2019-04-10 Pages: 4
Assignor
EIGER BIOPHARMACEUTICALS, INC.
Executed: 2019-03-28
Assignee
THERAGENE PHARMACEUTICALS, INC.
6150 LUSK BLVD, SUITE B 201, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
Fluorescence Resonance Energy Transfer Assays for Sarco/Endoplasmic Reticulum Calcium Atpase and Phospholamban
Patent: 8,431,356 →
Application: 13/145,787 →
Publication: US 2012/0021926
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 24, 2012
From: THOMAS, DAVID D.; CORNEA, RAZVAN L.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 027587/0341 →
Assignment of Assignor's Interest Jan 24, 2012
From: ZSEBO, KRISZTINA M.
To: CELLADON CORPORATION
Reel/Frame 027587/0450 →
Confirmatory License Nov 5, 2012
From: REGENTS OF THE UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029244/0490 →
Change of Name Apr 2, 2019
From: CELLADON CORPORATION
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 049108/0698 →
Merger Apr 2, 2019
From: CELLADON CORPORTION, A CALIFORNIA CORPORATION
To: CELLADON CORPORATION, A DELAWARE CORPORATION
Reel/Frame 048767/0852 →
Abstract of Judgment Aug 18, 2020
From: ZSEBO, KRISZTINA
To: THERAGENE PHARMACEUTICALS, INC.
Reel/Frame 053529/0133 →
Lien Aug 19, 2020
From: THERAGENE PHARMACEUTICALS, INC.
To: ZSEBO, KRISZTINA
Reel/Frame 053555/0715 →